Cargando…
EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS
Medulloblastoma (MB) is the most common high-grade primary brain malignancy in children and accounts for 1% of adult brain tumors. Previous studies have compared survival in pediatric and adult MB from the National Cancer Institute Surveillance Epidemiology and End Results (SEER) database finding no...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715848/ http://dx.doi.org/10.1093/neuonc/noaa222.189 |
_version_ | 1783619051696685056 |
---|---|
author | Moisander-Joyce, Hanna M Sinha, Anoushka Fernandez-Ledon, Shannon Lee, Davon T Hatano, Satoki Kahn, Justine Garvin, James H Zacharoulis, Stergios Gartrell-Corrado, Robyn D |
author_facet | Moisander-Joyce, Hanna M Sinha, Anoushka Fernandez-Ledon, Shannon Lee, Davon T Hatano, Satoki Kahn, Justine Garvin, James H Zacharoulis, Stergios Gartrell-Corrado, Robyn D |
author_sort | Moisander-Joyce, Hanna M |
collection | PubMed |
description | Medulloblastoma (MB) is the most common high-grade primary brain malignancy in children and accounts for 1% of adult brain tumors. Previous studies have compared survival in pediatric and adult MB from the National Cancer Institute Surveillance Epidemiology and End Results (SEER) database finding no difference. However, diagnostic subgroup analyses are limited. We examined survival in children (age 0–19) and adults (20–79) coded as MB in the 2018 SEER database (2000–2016), using Kaplan Meier analysis, log-rank test and Cox proportional hazard ratios (HR) with 95% confidence intervals (CI).). MB in SEER-18 is defined as ICD-O-3 histology codes 9470–9474 (n=1,728). ICD 9473, supratentorial PNET (sPNET, n=97) is biologically distinct so was analyzed separately. 5-year survival for MB, excluding sPNET, was similar in children (n = 1,091, 75.3%) and adults (n= 488, 79.1%) (HR=0.97, CI: 0.79 – 1.17, p=0.50). Subtype analyses showed no survival difference comparing adults and children with desmoplastic nodular MB (n=222, p=0.09), large cell MB (n=73, p=0.46), or MB NOS (n=1330, p=0.10). In contrast, children with sPNET had improved survival (n=65, 72.3%) compared to adults (n=29, 51.7%) (HR = 2.0, CI: 1.10 – 3.92; p=0.02,). In conclusion, 2018 SEER data for MB continue to show no survival difference between adults and children, suggesting adult patients could appropriately be entered on pediatric MB treatment protocols. Further analyses of the 2018 data are ongoing adjusting for sex, race, and treatment. Comparison of adults and children with MB and sPNET will be re-evaluated using the new 2016 World Health Organization classification. |
format | Online Article Text |
id | pubmed-7715848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77158482020-12-09 EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS Moisander-Joyce, Hanna M Sinha, Anoushka Fernandez-Ledon, Shannon Lee, Davon T Hatano, Satoki Kahn, Justine Garvin, James H Zacharoulis, Stergios Gartrell-Corrado, Robyn D Neuro Oncol Epidemiology Medulloblastoma (MB) is the most common high-grade primary brain malignancy in children and accounts for 1% of adult brain tumors. Previous studies have compared survival in pediatric and adult MB from the National Cancer Institute Surveillance Epidemiology and End Results (SEER) database finding no difference. However, diagnostic subgroup analyses are limited. We examined survival in children (age 0–19) and adults (20–79) coded as MB in the 2018 SEER database (2000–2016), using Kaplan Meier analysis, log-rank test and Cox proportional hazard ratios (HR) with 95% confidence intervals (CI).). MB in SEER-18 is defined as ICD-O-3 histology codes 9470–9474 (n=1,728). ICD 9473, supratentorial PNET (sPNET, n=97) is biologically distinct so was analyzed separately. 5-year survival for MB, excluding sPNET, was similar in children (n = 1,091, 75.3%) and adults (n= 488, 79.1%) (HR=0.97, CI: 0.79 – 1.17, p=0.50). Subtype analyses showed no survival difference comparing adults and children with desmoplastic nodular MB (n=222, p=0.09), large cell MB (n=73, p=0.46), or MB NOS (n=1330, p=0.10). In contrast, children with sPNET had improved survival (n=65, 72.3%) compared to adults (n=29, 51.7%) (HR = 2.0, CI: 1.10 – 3.92; p=0.02,). In conclusion, 2018 SEER data for MB continue to show no survival difference between adults and children, suggesting adult patients could appropriately be entered on pediatric MB treatment protocols. Further analyses of the 2018 data are ongoing adjusting for sex, race, and treatment. Comparison of adults and children with MB and sPNET will be re-evaluated using the new 2016 World Health Organization classification. Oxford University Press 2020-12-04 /pmc/articles/PMC7715848/ http://dx.doi.org/10.1093/neuonc/noaa222.189 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Epidemiology Moisander-Joyce, Hanna M Sinha, Anoushka Fernandez-Ledon, Shannon Lee, Davon T Hatano, Satoki Kahn, Justine Garvin, James H Zacharoulis, Stergios Gartrell-Corrado, Robyn D EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS |
title | EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS |
title_full | EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS |
title_fullStr | EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS |
title_full_unstemmed | EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS |
title_short | EPID-03. COMPARISON OF SURVIVAL IN ADULT AND PEDIATRIC PATIENTS WITH MEDULLOBLASTOMA: A 2018 SEER BASED ANALYSIS |
title_sort | epid-03. comparison of survival in adult and pediatric patients with medulloblastoma: a 2018 seer based analysis |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715848/ http://dx.doi.org/10.1093/neuonc/noaa222.189 |
work_keys_str_mv | AT moisanderjoycehannam epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT sinhaanoushka epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT fernandezledonshannon epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT leedavont epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT hatanosatoki epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT kahnjustine epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT garvinjamesh epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT zacharoulisstergios epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis AT gartrellcorradorobynd epid03comparisonofsurvivalinadultandpediatricpatientswithmedulloblastomaa2018seerbasedanalysis |